Sobin Chang, MPH, Chief Executive Officer
Over 20 years of experience in Management, Marketing, and Research in pharmaceuticals, devices, biologics as well as nutraceuticals from recognized brand BOTOX® to $7.5B oncology portfolio. She built her corporate track record with Pfizer, Bayer, Schering-Plough (Merck), Novartis and Allergan. Her breadth of experience in various therapeutic areas includes neuroscience, dermatology, infectious disease, allergy & immunology and oncology, which lead to over 20 inventions. She is a trained pharmacoeconomist and has over 60 publications. She was recently the opening keynote speaker for Big data in Pharma conference in Philadelphia. She served at the US Department of Health and Human Services, the Division of Drug Marketing, Advertising and Communications of the Food and Drug Administration (FDA DDMAC) providing guidance on the FDA Modernization Act. Sobin received her B.A. Honors in Mathematics with Magna Cum Laude from University of Missouri-Columbia, a Master of Public Health Degree (MPH) and post-doctoral fellowship in Biostatistics, Regulatory Affairs and Pharmacoeconomics from Yale School of Medicine. She is currently serving as a Director of the Board at AYAPH (Association of Yale Alumni in Public Health) and Chair, Business and Industry Committee.
David Shafer, MD, FACS, Chief Medical Technology Officer
David’s passion for innovation, technology, & improving the overall patient experience, has led him to create the world’s first-ever plastic surgery themed iPhone application. The App features over 1000 interactive FAQs about plastic surgery. Dr. Shafer launched the world’s first Vectra XT 3D Imaging System, allowing patients to view 3D simulated procedures on their own body prior to their surgery. In recent years, Dr. Shafer has written numerous peer-reviewed articles and chapters on facelift techniques, BOTOX Cosmetic®, Dysport™ and anesthesia for plastic surgery. Additionally, he has produced DVDs on BOTOX® Cosmetic® injections to teach other surgeons fundamental skills and new developments. Dr. Shafer has repeatedly been voted TOP DOC for Botox, Liposuction, Tummy Tuck, and Facelift among many other categories. Dr. Shafer is a NYC double board certified plastic surgeon, a Diplomat of the American Board of Plastic Surgery & a Member of the American Society of Plastic Surgeons. He was trained at the world renowned Mayo Clinic, which is consistently ranked as the best in class for hospitals and surgical training. Additionally, he completed a prestigious fellowship at MEETH, making him an expert in Aesthetic Surgery.
Kwonsoo Chun, PhD, Research & Development
Kwonsoo is a highly talented and accomplished engineer with specialization in identifying clinical needs, designing desired medical devices, and providing engineering solutions. He has extensive R&D experience and patents from Baylor College of Medicine’s Department of Neurosurgery. He has a broad background in biomedical engineering, electrical engineering, and mechanical engineering. He has experiences in designing and developing medical devices in order to treat spinal instability, cardiovascular disease, and obesity. At Stanford University, he researched on robotics and haptics and conducted actuator control such as motor and solenoid with operating a micro-processor. His previous works resulted in startups and publications through a number of collaborations with medical doctors and engineering team. He currently holds a faculty position at Baylor College of Medicine and has numerous publications in peer-reviewed journals. He received his Ph.D. in Mechanical Engineering from Stanford University.
Yuliana Dyukareva, Operations
For more than 10 years, Yuliana has been helping businesses grow by implementing the consumer and professional product brand strategies and driving the initiatives that build and maintain lifelong relationships with customers. A deep rooted passion for skin health led her to an international medical aesthetics company, Suisselle, in the injectables and cosmeceutical sub-sectors where she led the long-term growth and revenue maximization strategy. As a director of marketing and partnerships she was responsible for setting the creative direction, innovation and development of all the new strategic initiatives allowing the company to expand, vertically integrate, and differentiate among competitors, resulting in a successful expansion into over 45 countries in under four years. Prior to joining the aesthetics industry, Yuliana played a key role in guiding private investment firm, Park 49, client companies’ to achieve fundraising, investment, and business growth objectives. Having worked with various key players abroad, including business partners in France, Russia, Colombia, and Switzerland, Yuliana brings forth both global perspective and global etiquette into the medical aesthetics business sphere. She holds a B.A. from Lakeland College, Wisconsin and a Master's degree in Management from Harvard University.Back to Top
Steven Fagien, MD
Based in Boca Raton, Florida since 1989, Steven Fagien, MD is one of the foremost oculoplastic surgeons in the United States and the world. With a dedication to aesthetic eyelid plastic surgery, Dr. Fagien has built his reputation on challenging traditional techniques and developing cutting-edge advances that have become the benchmarks for a variety of procedures, and he continues to strive for innovation and excellence. Dr. Fagien focuses on creating the most beautiful, youthful eyes, paying careful attention to natural-looking results thanks to techniques he has developed. In addition to his unparalleled surgical skills, he also works with major pharmaceutical companies and the FDA to develop new injectable products for facial rejuvenation. As an educator and innovator, Dr. Fagien has authored over 300 publications in peer-reviewed journals, penned his own bestselling textbook on Cosmetic Oculoplastic Surgery, and has made more than 1,000 presentations about his techniques and best practices to surgeons around the globe. His international reputation and stature draw patients from Europe, Asia and beyond, proving Dr. Fagien’s position as one of the most sought-after oculoplastic surgeons worldwide.
Jill Waibel, MD
Jill practices as a board certified dermatologist specializing in general dermatology, cutaneous laser surgery and cosmetic dermatology for adults and children. She is in private practice in Miami, Florida and Coral Gables, Florida. She is currently the medical director and owner of the Miami Dermatology and Laser Institute in Miami. Dr. Waibel is the subsection chief of Dermatology at Baptist Hospital. In addition she serves as a Clinical Voluntary Assistant Professor at the University of Miami. She is a world-recognized leader in dermatologic laser surgery and lectures all over the world to train other physicians. In her practice she has over 40 laser devices and treats a wide variety of cutaneous disease. Dr. Waibel is active in basic science clinical trials at the University of Miami and has a clinical trials division Miami Dermatology and Research. One of Dr. Waibel’s primary passions is the treatment of scars by applying today’s latest cutaneous laser technologies. She has successfully developed industry-leading procedures and techniques with lasers, received numerous awards for her contributions to medicine, and published numerous peer-reviewed journal articles and several textbook chapters. Most recently Dr. Waibel was granted a Cutting Edge Research Grant by the American Society for Dermatologic Surgery.
Mary P. Lupo, MD
Since 1983, Mary P. Lupo, M.D., has been at the forefront of non-surgical skin rejuvenation. She realized at that time the desire for patients to look younger without the downtime and serious risks associated with surgery, as well as the importance of preventative care and maintenance of correction once it was achieved. She began using innovative combination protocols for her patients that included collagen fillers, light chemical peels, and topical products such as Retin A and alpha hydroxy acids with sun protection to make the skin look years younger. This trend is now the cornerstone of non-surgical care along with the additions of Botox to relax hyperactive muscles, newer more long-lasting fillers, and laser and other energy devices. Patients travel from miles away for the insight and experience that Dr. Lupo can provide to reshape and rejuvenate their faces without cutting. Dr. Lupo's patients understand that it is not the use of one particular filler or laser, but rather the application of these tools in tandem that achieves the best possible result. Dr. Lupo is a Board-certified dermatologist and clinical professor of dermatology at Tulane University School of Medicine. Dr. Lupo received a Bachelor of Science undergraduate degree in biology from Newcomb College of Tulane University where she graduated summa cum laude with honors, achieving the highest four-year grade point average of the graduating class of 1976. She graduated from Tulane University School of Medicine in 1980 and completed her internal medicine internship at Ochsner Foundation, before entering the dermatology program at Tulane University School of Medicine where she served as chief resident in her final year. Dr. Lupo was presented the Peterkin Award for her original research in skin lipids and inflammation in patients with atopic dermatitis. She is licensed to practice in Louisiana and Colorado.Back to Top
Brian O’Callaghan is currently the President & Chief Executive Officer of Petra Pharma, a New York based biotech company. He was previously President and Chief Executive Officer at Acucela, Sonrgy, and Sangart respectively. He has over 25 years of leadership experience in the biotechnology and pharmaceutical industries, having lived and worked in 5 different countries and both sides of the US, working for such companies as Pfizer in the UK, Merck Serono in Germany, BioPartners in Switzerland, Bayer in Ireland, and Novartis in the US. He has run both public and private companies, gaining extensive experience within areas such as fundraising, IPO's, BD, M&A, as well as all areas of product development and commercialization. He also brings extensive Board experience having served on numerous corporate, industry and non profit boards.
Thomas A. Albright
Tom has 35 years of experience in the field of pharmaceutical, biologic, device and aesthetic-related sales, marketing and general management roles. He currently serves as the CEO of Recros Medica and Chairman and CEO of Andrew Technologies. Prior to that, he was president of the topical aesthetic division at Syneron Medical, Head of North American marketing at Nobel Biocare. His medical aesthetic experience commenced with Allergan (2000 – 2008), where he led the launch of BOTOX® Cosmetic and the commercial development of Latisse®. He was also the alliance manager for the collaboration between Allergan and GlaxoSmithKline in China, Japan, and the US. In 1983, he commenced his career in healthcare with the Parke-Davis division of Warner Lambert, where he held sales and marketing leadership roles, including the 1997 launch of Lipitor®, among other brands. Tom has a BS in biology from The Citadel and an MBA in marketing from Mercer University.
B.G. Rhee, Ph.D
B.G. Rhee is the Vice Chairman of CKD Pharma. He was previously the CEO of Green Cross Holdings, Inc. and the President of Green Cross Corp., President and CEO of Expression Genetics, Head of Pharmaceutical Business Unit of Samyang Corporation and Head of Drug Development Center of LG Chem (Currently LG Life Science). B.G. Rheewas was also President of BIO Korea, Member of the National Academy of Engineering Korea, Co-Chairman of HT Forum, and Member of the Science and Technology Committee, Federation of Korean Industries. He got his education from Rice University and Seoul National University.
Youngjay Paik, PhD
Young-Jay is currently the Senior Director of Google, EVP Google Korea. He wa previously the CEO of Blizzard Entertainment in Korea. He has experiences in working at global consulting firms including McKinsey & Company and Booz & Co., where he carried out diverse projects such as marketing strategy, operational improvement, new business development, change management, performance management, etc. in banking, telecom, healthcare, real estate, automotive, high tech, and heavy industries. Young-Jay earned a BA in Anthropology from Seoul National University, a Ph.D in Anthropology from Yale University, and a MRED from USC.
Sharon Tonetta, PhD
Sharon Tonetta is Vice President of Regulatory Affairs of Valeant Pharmaceuticals. She was previously Vice President of Global Regulatory Affairs at Bausch & Lomb, Allergan, Maxim Pharmaceuticals, Baxter Healthcare, and Baxter International. Sharon Tonetta has a Ph.D. in Animal Science & Physiology from Michigan State University and a B.A. in Biology from Cornell College.
Mr. Lippin is President & CEO of Bolder Industrial Performance Services. Prior to Bolder, he was Honeywell’s Vice President General Manager of Asia Pacific in Shanghai, China, Vice President and General Manager Lifecycle Solutions and Services in Bracknell, UK and Vice President of Global Sales in US.
Michael Piraino, CPA
Michael Piraino serves as the Chief Financial Officer and Executive Vice President of Accelrys Software Inc. With almost 30 years experience in Senior Executive and Financial roles, Mr. Piraino has broad depth of expertise in financial and operational management. He has served in the past in Accelrys Software, CRS Retail Technology Group, CEO Resources, Symyx Technologies, Epicor Software Corporation, Accelrys, Enfrastructure (now known as TechSpace), SM&A, Data Processing Resources Corporation. He has served as senior management in bitotech companies such as Imagyn Medical Technologies, Syncor International Corporation, Total Pharmaceutical Care. Mr. Piraino is a Certified Public Accountant, and member of the American Institute of Certified Public Accountants and the California Society of Certified Public Accountants. He holds a B.S. Degree in Accounting from Loyola University.
Sandeep Duttagupta, PhD
Sandeep Duttagupta, PhD, Principal and Vice President at CBPartners, has spent almost two decades in the areas of value assessment, market access, pricing and health economics of pharmaceutical and biotechnology products. In his current role, Dr. Duttagupta is responsible to build the health care practice in Emerging Markets for CBPartners. Prior to joining the consulting firm, Dr. Duttagupta was the Head of Market Access & Pricing supporting Pfizer's Emerging Market Business Unit. A trained health economist, Sandeep was previously responsible for providing Health Outcomes support to the countries in Asia, Latin America, Africa, and Middle East. Sandeep joined Pfizer in 1996, and was responsible for planning and implementing health economic and outcomes research strategies. Sandeep has a B.S. in Pharmacy from Calcutta, India and Ph.D. in Health Care Administration from University of Louisiana, Monroe.Back to Top